Rome, Italy

Emanuele Salvinelli


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 832,718 
Other
 patents

Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emanuele Salvinelli: Innovator in Neurological Therapy

Introduction

Emanuele Salvinelli is a notable inventor based in Rome, Italy. He has made significant contributions to the field of neurological therapy through his innovative approaches. His work focuses on the intranasal administration of agents that have pro-inflammatory activity, aimed at treating neurological disorders.

Latest Patents

Salvinelli holds a patent for his invention titled "Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders." This invention involves a product that consists of distilled water or an aqueous solution that is hypotonic or isotonic with respect to blood plasma. The method of administration is designed to cause an irritative inflammation in the nasal mucosa, which stimulates the endogenous production of inflammatory mediators. These mediators play a crucial role in the therapy and prevention of neurological disorders, particularly degenerative conditions affecting the central and peripheral nervous systems.

Career Highlights

Throughout his career, Emanuele Salvinelli has focused on advancing therapeutic methods for neurological conditions. His innovative patent reflects his commitment to improving treatment options for patients suffering from these disorders.

Collaborations

Salvinelli has collaborated with notable individuals in his field, including Fabrizio Salvinelli and Beatrice Salvinelli. Their combined expertise contributes to the advancement of research and development in neurological therapies.

Conclusion

Emanuele Salvinelli's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of neurological disorders. His patent highlights the potential for new therapeutic approaches that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…